Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemia

Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.

341 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemia trial results

Completed

A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

NCT00136942

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Pfizer Investigational Site Binningen, Basel-Landschaft, Switzerland
  • Pfizer Investigational Site Liestal, Basel-Landschaft, Switzerland
  • Pfizer Investigational Site Basel, Canton of Basel-City, Switzerland
  • Pfizer Investigational Site Langenthal, Canton of Bern, Switzerland
View all 20 locations
View Trial Details
Completed

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

NCT00143234

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Argentina
View all 118 locations
View Trial Details
Completed

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

NCT00174304

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations
  • Pfizer Investigational Site Salzburg, Austria
  • Pfizer Investigational Site Sankt Pölten, Austria
  • Pfizer Investigational Site Vienna, Austria
  • Pfizer Investigational Site Wels, Austria
View all 102 locations
View Trial Details
Completed

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

NCT00174330

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Completed

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2

NCT01763905

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
Locations
  • Research Site Carmichael, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Mission Viejo, California, United States
  • Research Site Thousand Oaks, California, United States
View all 58 locations
View Trial Details
Completed

Patient and Provider Assessment of Lipid Management Registry

NCT02341664

Conditions
Angina, Angina Pectoris, Angina, Unstable, +62 more
Locations
  • Cardiology and Medicine Clinic Little Rock, Arkansas, United States
  • COR Healthcare San Pedro, California, United States
  • Ventura Cardiology Consultants Medical Group, Inc Ventura, California, United States
  • Maya Research Center, Inc Hialeah, Florida, United States
View all 14 locations
View Trial Details

Related conditions